Pediatr Endocrinol Diabetes Metab
February 2016
Introduction: Pump discontinuation is rare. It is estimated that only about 4% of patients return to multiple daily injections (MDI).
Objective: To study the factors that influence the decision to stop continuous subcutaneous insulin infusion therapy (CSII).